Turer Aslan T, Mahaffey Kenneth W, Compton Kate L, Califf Robert M, Schulman Kevin A
Division of Cardiology, Department of Medicine, Duke University Medical Center, Durham, NC, USA.
Am Heart J. 2007 Apr;153(4):674-80. doi: 10.1016/j.ahj.2007.01.005.
Nonpublication of research results threatens the integrity of clinical research, but the extent of nonpublication and factors associated with publication remain poorly documented. We sought to examine rates of publication or presentation of research findings from multicenter clinical trials and determine what factors are associated with dissemination of results.
We conducted a follow-up study of 217 prospective, multicenter clinical trials of treatment approved in 1998 by the institutional review board of a large academic medical center, of which 197 had enrolled participants and were not known to be ongoing. Follow-up included searches of the literature and the Internet and telephone and e-mail inquiries to investigators and research sponsors. The main outcome measures were manuscript publication or other presentation of research results.
Results of 110 (56%) out of 197 multicenter clinical trials have been published in the peer-reviewed literature. Results of 87 (44%) studies have not been published, and results of 52 (26%) studies have not been disseminated in any form. The rate of dissemination of trial results was highest for studies that were phase 3 (81%), lowest risk (86%), and investigational (76%). The dissemination rate was lowest for studies that were supported by internal funds (50%). However, none of these associations were statistically significant.
Results of almost half of the multicenter clinical trials conducted in part at a large academic medical center have never been published. Mechanisms to ensure public dissemination of clinical trial results are needed.
研究结果未发表威胁到临床研究的完整性,但未发表的程度以及与发表相关的因素仍缺乏充分记录。我们试图研究多中心临床试验研究结果的发表或报告率,并确定哪些因素与结果的传播有关。
我们对一家大型学术医疗中心的机构审查委员会于1998年批准的217项前瞻性多中心治疗临床试验进行了随访研究,其中197项已招募参与者且已知并非仍在进行中。随访包括文献检索、互联网搜索以及对研究者和研究资助者的电话和电子邮件询问。主要结局指标是研究结果的论文发表或其他形式的报告。
197项多中心临床试验中的110项(56%)结果已在同行评审文献中发表。87项(44%)研究结果未发表,52项(26%)研究结果未以任何形式传播。3期试验(81%)、低风险试验(86%)和研究性试验(76%)的试验结果传播率最高。内部资金支持的研究传播率最低(50%)。然而,这些关联均无统计学意义。
在一家大型学术医疗中心部分开展的多中心临床试验中,近一半的结果从未发表。需要建立确保临床试验结果公开传播的机制。